ROCKVILLE, Md. — The American Society of Human Genetics (ASHG) has officially announced the recipients of its 2026 Professional Awards, a prestigious slate of honors recognizing seven individuals who have fundamentally altered the landscape of human genetics and genomics. The awards, which span research, mentorship, advocacy, and education, underscore the society’s commitment to fostering a field that is as scientifically rigorous as it is socially impactful.
The honorees will be formally recognized during the 2026 ASHG Annual Meeting, scheduled for October 20–24 in Montréal. The ceremony serves as a highlight of the world’s largest gathering of genetics professionals, marking a moment to reflect on the rapid evolution of genomic medicine and the pioneers driving it forward.
A Vision for the Future: Leadership in Genomics
The 2026 awards recognize a spectrum of contributions, ranging from foundational population genetics to the cutting edge of CRISPR-based therapeutics.
“ASHG is honored to recognize this exceptional group of awardees, whose work demonstrates the many ways human genetics and genomics can advance science and serve society,” said Dr. Susan A. Slaugenhaupt, President of the ASHG. “Each honoree has helped shape a stronger, more collaborative, and more impactful field. Their achievements inspire our community and reflect the promise of genetics to improve lives around the world.”
The 2026 Laureates: A Chronology of Impact
The achievements of these seven individuals span decades, creating a timeline of discovery that has evolved from basic mapping to the era of precision medicine.
The Foundation Builders (Lifetime and Leadership)
- Dr. Yusuke Nakamura (Lifetime Achievement Award): Dr. Nakamura’s career is a masterclass in scientific endurance. From his pioneering work on Variable Number Tandem Repeat (VNTR) markers in the 1980s—which provided the bedrock for the positional cloning era—to his contemporary leadership as President of the National Institutes of Biomedical Innovation, Health and Nutrition in Japan, his influence is pervasive. His role in the International HapMap Project and the establishment of BioBank Japan created the essential infrastructure that now supports global precision medicine.
- Dr. Aravinda Chakravarti (Leadership Award): As the Director of the Center for Human Genetics and Genomics at NYU Grossman School of Medicine, Dr. Chakravarti has been a primary architect of modern human genetics. His early work on cystic fibrosis and his leadership in the Human Genome Project set the standard for international collaboration. His ability to translate complex statistical genetics into actionable medical insights has defined the last thirty years of the field.
The Innovators (Scientific Achievement and Early Career)
- Dr. Wendy Chung (Scientific Achievement Award): Dr. Chung’s career represents the pinnacle of translational research. Based at Boston Children’s Hospital, she has successfully bridged the gap between the laboratory bench and the patient’s bedside. By identifying over 60 new disease-causing genes, she has transformed the diagnosis and treatment of conditions ranging from metabolic disorders to autism.
- Dr. Rebecca Ahrens-Nicklas (Early Career Award): Dr. Ahrens-Nicklas stands at the vanguard of the next generation of genetic medicine. Her work at the Children’s Hospital of Philadelphia—specifically her development of the world’s first personalized in vivo CRISPR therapy for an infant—marks a turning point in how the field approaches ultra-rare diseases. Her research signals a future where "precision medicine" is not just a concept, but a tangible, individualized reality.
The Communicators and Mentors (Advocacy, Education, and Mentorship)
- Roxanne Khamsi (Advocacy Award): In an era of rampant misinformation, Ms. Khamsi’s work as a science journalist has been a beacon of clarity. Through her contributions to The Atlantic, WIRED, and her recent book Beyond Inheritance, she has challenged the public and the scientific community to move past reductive views of genetics. Her ability to synthesize complex data into compelling human narratives is vital for the public understanding of science.
- Dr. Robbee Wedow (Education Award): A sociologist and data scientist at Purdue University, Dr. Wedow has revolutionized how genetics is taught. Through the "Humane Genetics Curriculum," he has equipped students to navigate the intersection of race, ancestry, and genetics with precision and social responsibility. His work ensures that the next generation of policy makers and medical professionals are culturally competent in their use of genomic data.
- Dr. Nancy B. Spinner (Mentorship Award): Mentorship is the lifeblood of scientific progress. Dr. Spinner, now at Northwell Health, is recognized for a 35-year legacy of cultivating talent. By training over 23 laboratory directors and dozens of other researchers, she has built a network of scientists who are now leading the field. Her philosophy—that mentorship must be individualized and focused on the long-term potential of the trainee—remains a gold standard for academic medicine.
Supporting Data and Institutional Context
The selection of these awardees reflects the strategic priorities of the ASHG. The society represents nearly 8,000 professionals, and the 2026 awards highlight a deliberate shift toward three core areas:
- Clinical Integration: The shift from discovery to treatment is exemplified by the work of Drs. Chung and Ahrens-Nicklas.
- Infrastructure and Data: The career paths of Dr. Nakamura and Dr. Chakravarti emphasize that individual brilliance is most effective when supported by large-scale, international data-sharing initiatives.
- Social Responsibility: The recognition of Dr. Wedow and Ms. Khamsi indicates that ASHG prioritizes the ethical and educational implications of genomic research as much as the biological findings themselves.
The impact of these individuals is best measured by the infrastructure they have left behind. For example, the BioBank Japan project, spearheaded by Dr. Nakamura, has provided the data necessary for thousands of subsequent papers, while Dr. Chung’s collaborative research model has become the blueprint for rare disease consortiums globally.
Official Responses and Reflections
Dr. Susan A. Slaugenhaupt emphasized that these awards are not merely "lifetime achievement" markers, but a reflection of a field in constant motion.
"The 2026 honorees represent the full lifecycle of scientific progress," Dr. Slaugenhaupt remarked during the press briefing. "We have the foundational architects who built the tools, the clinicians who are using those tools to save lives, and the educators and storytellers who are ensuring that society understands and benefits from these advancements. It is a holistic picture of where human genetics is headed."
The honorees themselves have often noted that the "collaborative nature" of their work is the key to their success. In recent interviews, both Dr. Chung and Dr. Spinner highlighted that their greatest breakthroughs were the result of multi-disciplinary teams—bringing together geneticists, clinicians, ethicists, and patients—to solve problems that no single department could address alone.
Implications for the Field: Beyond 2026
The awarding of these prizes at the 2026 Annual Meeting is set against a backdrop of rapid regulatory and technological change. With the rise of CRISPR-based therapies and the increasing integration of polygenic risk scores into routine clinical care, the work of this year’s honorees provides a roadmap for the future.
Key Implications include:
- Precision Medicine at Scale: The transition from identifying a gene to developing a custom therapy, as seen in Dr. Ahrens-Nicklas’s work, suggests that the cost and time of drug development for rare diseases will continue to decrease.
- Addressing Health Disparities: The work of Dr. Wedow and Dr. Chakravarti emphasizes the necessity of diversity in genomic databases. By understanding the nuance of genetic variation across populations, the field is working to ensure that precision medicine does not widen existing health disparities.
- The Changing Role of the Geneticist: As genomics becomes integrated into every facet of medicine, the role of the geneticist is shifting from a specialist in a lab to a consultant who must communicate with patients, policymakers, and the public. The recognition of Ms. Khamsi’s journalism underscores that the ASHG sees public engagement as a critical component of professional success.
Conclusion
As the community gathers in Montréal this October, the 2026 ASHG Professional Awards will serve as more than just a ceremony. They will serve as a synthesis of the progress made over the last four decades and a declaration of intent for the next.
For the thousands of researchers, clinicians, and students who will be in attendance, these honorees provide a template for success that balances technical mastery with humanitarian concern. As the field of human genetics continues to push the boundaries of what is biologically possible, the legacy of these seven individuals will undoubtedly provide the foundation for the next generation of medical miracles.
About the American Society of Human Genetics (ASHG):
Founded in 1948, the ASHG is the primary professional membership organization for human genetics specialists worldwide. The society publishes The American Journal of Human Genetics and Human Genetics and Genomics Advances, and remains the central hub for policy, research, and educational standards in the field. For more information, visit www.ashg.org.
About the Author
